A director of Square Pharmaceuticals plc, Tapan Chowdhury, purchased 2 million shares of the company. On March 11, he announced his intention to buy these shares at the existing market price on the Dhaka Stock Exchange (DSE), as revealed by DSE sources. Square Pharmaceuticals, which went public in 1995, has an authorized capital of Tk 1,000 crore and a paid-up capital of Tk 886.45 crore. The company’s reserve stands at a staggering Tk 10,429.6 crore. Its total number of shares is 88.64 million, with entrepreneurial managers owning 35.14%, institutions holding 15.22%, foreigners holding 13.95%, and common investors holding the remaining 35.69%. The company’s impressive financial position and Chowdhury’s substantial share purchase highlight the company’s strong performance and investor confidence. Square Pharmaceuticals’ solid fundamentals and growth prospects have likely driven this significant investment by one of its directors, signaling positive sentiment in the company’s future.
BIZDATAINSIGHTS
Bizdata Insights is a Market Insights, Data Intelligence and Business Advisory Platform
Our Solutions
Menu
Newsletter
Sign up for our newsletter now by entering your e-mail address and never miss out on the latest news and updates from our team!